Laxmi Dental IPO
IPO Open
-
IPO Close
-
Price Band
-
Market Cap (Pre-IPO)
-
IPO Details
| IPO Date | - |
| Listing Date | - |
| Face Value | - |
| Price Band | - |
| Lot Size | - |
| Sale Type | - |
| Issue Type | - |
| Listing At | NSE,BSE |
| Issue Size | - |
Laxmi Dental IPO Lot Size
Investors can bid for a minimum of 33 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 33 | ₹14,124 |
| Retail (Max) | 14 | 462 | ₹197,736 |
| S-HNI (Min) | 15 | 495 | ₹211,860 |
| S-HNI (Max) | 70 | 2,310 | ₹988,680 |
| B-HNI (Min) | 71 | 2,343 | ₹1,002,804 |
Laxmi Dental Financial Information (Restated Consolidated)
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 158.22 | 134.52 | 96.54 |
| Total Income | 117.90 | 195.26 | 163.84 |
| Profit After Tax | 22.74 | 25.23 | -4.16 |
| EBITDA | 0.00 | 0.00 | 0.00 |
| NET Worth | 67.09 | 44.57 | 19.48 |
| Reserves and Surplus | 0.00 | 0.00 | 0.00 |
| Total Borrowing | 40.91 | 42.03 | 31.44 |
Amount in ₹ Cr
Key Performance Indicators
As of Sunday, March 31, 2024| KPI | Values |
|---|---|
| ROE (Return on Equity) | 78.78% |
| ROCE (Return on Capital Employed) | 19.97% |
| Debt/Equity | 0.94 |
| RoNW (Return on Net Worth) | 78.78% |
| PAT Margin (Profit After Tax Margin) | 13.03% |
| EBITDA Margin | 49.59% |
| Price to Book Value | 0.00 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 4.88 | 8.27 |
| P/E (x) | 87.77 | 51.73 |
| Promoter Holding | 46.56% | 41.70% |
Company Promoters
- Rajesh Vrajlal Khakhar
- Sameer Kamlesh Merchant and Dharmesh Bhupendra Dattani are the promoters of the company.n
Company Overview
Incorporated in July 2004, Laxmi Dental Limited is an integrated dental products company. The company offers custom crowns and bridges, branded dental items like clear aligners and thermoforming sheets, aligner-related products as part of its aligner solutions, and pediatric dental products.
Their product portfolio includes custom crowns and bridges, clear aligners, thermoforming sheets, pediatric dental products, and more.
The company offers thermoforming sheets, biocompatible 3D printing resins, and machines for manufacturing clear aligners under the brand name Taglus.
The company operate a fully integrated model, meaning they handle the entire process from design and manufacturing to distribution of dental products.
As of September 30, 2024, the company has six manufacturing facilities: three in Mira Road, Mumbai, two in Boisar, and one in Kochi, along with five supporting facilities in Mumbai, Delhi, Bengaluru, and Ahmedabad.
As of September 30, 2024, the company’s dental network includes over 22,000 clinics and dentists across more than 320 cities nationwide.
The company has significant presence in both domestic and international markets, exporting to over 90 countries.
As of September 30, 2024, the company had 2,372 employees in various departments.
Company Strengths
- The only integrated dental products company in India, well-positioned to capture industry tailwinds;
- Second largest player in domestic laboratory business and largest export laboratory with increasing adoption of digital dentistry;
- Vertically integrated diverse branded product portfolio;
- Large Dental Network provide a competitive advantage in the market;
- Robust technologically advanced capabilities with stringent regulatory compliance ensuring high quality standards.
Use of Proceeds
| 1) | Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by the Company. | 22.98 |
| 2) | Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings. | 4.60 |
| 3) | Funding the capital expenditure requirements for purchase of new machinery for the Company | 43.51 |
| 4) | Investment in the Subsidiary, Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery | 25.00 |
| 5) | General corporate purposes | 32.08 |
Objectives
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
Laxmi Dental IPO Peer Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Laxmi Dental Limited | 4.80 | 4.80 | 8.63 | 87.77 | 78.78 | 53.50 | - |
| Poly Medicure Ltd. | 26.92 | 26.90 | 153.22 | 94.02 | 19.05 | 16.53 | - |
Quick Info
| Sector | Healthcare Supplies & Equipment |
| Exchange | NSE,BSE |
Important Dates
| IPO Open | - |
| IPO Close | - |
| Listing Date | - |
Description
Laxmi Dental IPO is a book build issue of ₹698.06 crores. The issue is a combination of fresh issue of 0.32 crore shares aggregating to ₹138.00 crores and offer for sale of 1.31 crore shares aggregating to ₹560.06 crores.
Laxmi Dental IPO bidding started from Jan 13, 2025 and ended on Jan 15, 2025. The allotment for Laxmi Dental IPO was finalized on Jan 16, 2025. The shares got listed on BSE, NSE on Jan 20, 2025.
Laxmi Dental IPO price band is set at ₹428.00 per share . The lot size for an application is 33. The minimum amount of investment required by an retail is ₹14,124 (33 shares) (based on upper price). The lot size investment for sNII is 15 lots (495 shares), amounting to ₹2,11,860, and for bNII, it is 71 lots (2,343 shares), amounting to ₹10,02,804.